Percutaneous Coronary Intervention in Elderly Patients with Coronary Chronic Total Occlusions: Current Evidence and

Lei Guo1, Hai-Chen Lv1, Rong-Chong Huang2

  • 1Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.

Insights

Elderly patients with coronary chronic total occlusions (CTO) can benefit from percutaneous coronary intervention (PCI). Despite higher risks, modern CTO-PCI techniques offer safe and effective treatment options for this growing population.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Background:

  • The global elderly population is increasing, leading to a higher prevalence of coronary chronic total occlusions (CTO) in older individuals.
  • Elderly patients often present with more extensive coronary artery disease, greater ischemic burden, and increased cardiovascular event risk compared to younger patients.
  • While coronary revascularization may offer significant benefits, interventional cardiologists often hesitate due to perceived higher operative risks in this demographic.

Purpose of the Study:

  • To review the current evidence regarding percutaneous coronary intervention (PCI) for coronary chronic total occlusions (CTO) in elderly patients.
  • To explore the safety, efficacy, and outcomes of CTO-PCI in the geriatric population.
  • To discuss future perspectives and the need for established guidelines for managing elderly CTO patients.

Main Methods:

  • Review of recent literature on CTO-PCI in elderly patients.
  • Analysis of data on success rates, complication profiles, and clinical outcomes.
  • Synthesis of evidence on the benefits and risks of revascularization in this specific patient group.

Main Results:

  • Advancements in dedicated CTO-PCI equipment and techniques have improved success rates and reduced complications.
  • CTO-PCI procedures are increasingly recognized as safe and effective for elderly patients.
  • Despite advancements, there is a lack of widely accepted consensus or guidelines for treating CTO in this population.

Conclusions:

  • Percutaneous coronary intervention (PCI) is a viable and effective treatment option for elderly patients with coronary chronic total occlusions (CTO).
  • Continued refinement of CTO-PCI techniques enhances safety and efficacy in geriatric patients.
  • Further research and guideline development are crucial to optimize the management and understand the long-term prognosis of CTO in the elderly.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
171
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
170
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
522
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
134
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
153
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
282